Suchergebnisse - "Silva, Inês"

PubPharm (10)

1

Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma

enthalten in: Nature communications | 2024

von Bai, X. | Attrill, G. | Gide, T. | +12

2

Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Rogiers, A. | Dimitriou, F. | Lobon, I. | +8

3

Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Weppler, A. | Da Meda, L. | Pires da Silva, I. | +13

4

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Wong, S. | Blum, S. | Sun, X. | +27

5

CTLA-4 Blockade Resistance after Relatlimab and Nivolumab

enthalten in: The New England journal of medicine | 2022

von Menzies, A. | Pires da Silva, I. | Trojaniello, C. | +10

CommentOn: N Engl J Med. 2022 Jan 6;386(1):24-34. - PMID 34986285

6

The effect of organ-specific tumor microenvironments on response patterns to immunotherapy

enthalten in: Frontiers in immunology | 2022

von Conway, J. | Braden, J. | Wilmott, J. | +3

7

Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Ch'ng, S. | Uyulmaz, S. | Carlino, M. | +17

8

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy : a multicentre, retrospective, cohort study

enthalten in: The Lancet. Oncology | 2021

von Pires da Silva, I. | Ahmed, T. | Reijers, I. | +25

CommentIn: Lancet Oncol. 2021 Jun;22(6):746-748. - PMID 33989555

9

G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Kelly, G. | Al-Ejeh, F. | McCuaig, R. | +13

10

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

enthalten in: Journal for immunotherapy of cancer | 2021

von Rogiers, A. | Pires da Silva, I. | Tentori, C. | +46

ErratumIn: J Immunother Cancer. 2021 Oct;9(10):. - PMID 34645678

1
[1]